Novartis grabs early FDA approval of lung cancer drug Zykadia

John Carroll

After a quick march through the clinic, has won FDA for the new "breakthrough" ceritinib (or LDK378), which will now be launched as .

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS